Evidence map›Paper›PMID 42657043›Full record

ArticleBiochemistry and biophysics reports2026

Surface protein profiling reveals depot-specific features of subcutaneous and visceral adipose progenitor cells.

Kazuki Hachiya, Nobuo Yamasaki, Hiroto Fukai, Yuki Uchida, Yuka Nozaki, Yuhei Mizunoe, Yoshikazu Higami

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazuki HachiyaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Nobuo YamasakiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Hiroto FukaiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Yuki UchidaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Yuka NozakiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Yuhei MizunoeLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Yoshikazu HigamiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White adipose tissue is organized into anatomically and functionally distinct depots, yet the mechanisms by which intrinsic differences between subcutaneous and visceral adipose progenitor cells (APCs) contribute to depot-specific inflammatory and remodeling properties remain unresolved. Here, by directly comparing APCs isolated from subcutaneous and visceral fat, we identify distinct surface protein programs underlying their divergent functional properties. Subcutaneous APCs exhibited elevated expression of galectin-9, CD44, and CD63, defining functional programs governing immune modulation, adipogenesis, and exosome-mediated stress adaptation. Functional assays revealed that galectin-9 promotes an anti-inflammatory phenotype, CD44 quantitatively modulates adipogenic differentiation, and CD63 enhances exosome release and confers resistance to iron-induced cellular stress. Notably, several depot-specific features were not evident at the transcriptomic level, underscoring the importance of surface protein-level regulation. Together, our findings demonstrate that APC surface protein signatures distinguish subcutaneous from visceral fat, establishing a mechanistic link between depot identity, tissue remodeling, and metabolic disease susceptibility.

Identifiers

PMID42657043
PMCPMC13507801

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.